KT&G Reports Lower-than-Expected First Quarter Financial Performance

Business by 2FIRSTS.ai
May.11.2024
KT&G Reports Lower-than-Expected First Quarter Financial Performance
KT&G (KRX:033780) reported a Q1 operating profit decrease, at 15% below market expectations, despite strong overseas performance.

Recently, Korean tobacco manufacturer KT&G (KRX: 033780) announced its first-quarter financial performance ending on March 31, 2024. The company reported a total revenue of 1.292 trillion Korean won (approximately $940 million) and an operating profit of 236.6 billion Korean won (approximately $170 million). According to IBK Investment Securities, KT&G's operating profit in the first quarter was about 15% lower than market expectations.

 

IBK Investment Securities analyst Kim Tae-hyeon stated, "KT&G's first quarter total sales were 129.2 billion Korean won (approximately 940 million US dollars), a year-on-year decrease of 7.4%. Operating profit was 236.6 billion Korean won (approximately 170 million US dollars), a decrease of 25.3%."

 

In particular, KT&G's overseas and domestic Next Generation Products ("NGP") and overseas cigarette business maintained strong performance in the first quarter of 2024, continuing the strong trend from last year.

 

In the first quarter of 2024, the core growth driver of NGP business – NGP stick volume achieved growth in all key indicators such as sales, revenue, operating profit, etc. The overseas NGP stick sales saw a double-digit growth of 14.7%, reaching 2.11 billion units. Driven by strategic pricing strategies in core growth markets such as Indonesia, KT&G's overseas cigarette business also achieved revenue growth for the third consecutive quarter. KT&G's first quarter revenue from overseas cigarettes was 291.8 billion Korean won (approximately 210 million USD), a 10.1% increase compared to the same period last year.

 

Despite achieving significant performance in core business areas, the company saw a decline in overall revenue and operating profit in the first quarter compared to the same period last year. This downturn was primarily due to increases in manufacturing costs, the completion of large real estate development projects, and a decrease in consumer spending resulting in a reduction in revenue in the health functional food industry.

 

A spokesperson for KT&G stated, "KT&G is committed to enhancing competitiveness in core business areas, driving business transformation, and aiming to achieve a major leap forward to become a world-class company." The spokesperson added, "Despite facing pressures from inflation-driven manufacturing costs and economic downturns, KT&G is striving to turn its business around and achieve profitability in the second half of the year by strengthening global competitiveness and pursuing operational efficiency optimization."

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Gumipod Accuses Altria of Misusing Confidential Technology for “On!” Nicotine Pouches
Gumipod Accuses Altria of Misusing Confidential Technology for “On!” Nicotine Pouches
Gumipod Group, Ltd. files federal lawsuit against Altria Group for alleged theft of trade secrets in packaging "On!" nicotine pouches.
Aug.26 by 2FIRSTS.ai
Iowa E-Cigarette Law Challenged: Industry Claims New Rules Will Destroy the Industry and Violate FDA Enforcement Discretion
Iowa E-Cigarette Law Challenged: Industry Claims New Rules Will Destroy the Industry and Violate FDA Enforcement Discretion
E-cigarette sellers and buyers asked the Eighth Circuit Court to keep blocking Iowa's HF 2677 bill. The bill would make all e-cigarettes sold in Iowa get FDA approval. They say the federal Food, Drug, and Cosmetic Act blocks this law, as it steps on FDA's toes by adding penalties where FDA didn't act. If the bill goes through, businesses might close and people could lose tools to quit smoking.
Aug.28 by 2FIRSTS.ai
2Firsts Exclusive: Dr. Zdinak Analyzes FDA’s Rejection of blu, Citing Lack of Behavioral Evidence
2Firsts Exclusive: Dr. Zdinak Analyzes FDA’s Rejection of blu, Citing Lack of Behavioral Evidence
In a 2Firsts exclusive, ARAC’s Dr. Zdinak explains FDA’s blu rejection stems from weak behavioral science data and urges companies to strengthen Module 6 studies immediately.
Aug.20
Jakarta’s Smoke-Free Zone Legislation Faces Criticism – Public Health Advocate: “It Will Not Harm Small Businesses”
Jakarta’s Smoke-Free Zone Legislation Faces Criticism – Public Health Advocate: “It Will Not Harm Small Businesses”
Jakarta’s new regulation is expected to improve public health, while experts call for collective efforts to counter misinformation, stressing that smoke-free zone policies can balance both health and economic development.
Aug.20 by 2FIRSTS.ai
Research Brief | Current Use of Cigarettes, E-Cigarettes, and Cannabis Is Significantly Associated with Xerostomia
Research Brief | Current Use of Cigarettes, E-Cigarettes, and Cannabis Is Significantly Associated with Xerostomia
About 9.7% of 29,721 U.S. adults (18+) surveyed in 2022–2023 reported their mouth felt dry “frequently” or “always.” After multivariable adjustment, past-30-day use of cigarettes (AOR ≈ 1.52), e-cigarettes (≈ 1.46), or cannabis (≈ 1.57) was each linked to higher odds of xerostomia. Daily use showed stronger associations (cigarettes ≈ 1.67; e-cigarettes ≈ 1.80; cannabis ≈ 2.15). Concurrent use of all three products had the highest odds (AOR ≈ 3.80). The authors suggest dental professionals factor
Sep.12 by 2FIRSTS.ai
BBC Uncovers Dealers Selling Spice-Laced Vapes to Teens via Snapchat
BBC Uncovers Dealers Selling Spice-Laced Vapes to Teens via Snapchat
A BBC undercover investigation in Warwickshire found drug dealers using Snapchat to sell vapes laced with spice (a potent, addictive drug) to teenagers, falsely claiming they contained THC (cannabis-derived). The operation, which involved a reporter posing as a schoolgirl, confirmed the vapes contained spice. Two mothers highlighted their 13-year-old daughters’ addiction to such products, with severe effects including collapses and traumatic withdrawal.
Sep.08